Top Markets
#1 Purr Purr +53.84%
#2 Smilek to the Bank Smilek to the Bank +50.56%
#3 龙虾 (Lobster) 龙虾 (Lobster) +23.47%
#4 Pons Pons +23.13%
#5 Non-Playable Coin Non-Playable Coin +20.70%
#6 OriginTrail OriginTrail +19.75%
#7 ApeX ApeX +18.50%
#8 Morpho Morpho +17.90%
#9 Not in Employment, Education, or Training Not in Employment, Education, or Training +17.62%
#10 Zora Zora +17.49%
Coin of the day
Purr Purr
Einstellungen
Sprache
DEUTSCH
Währung
USD
Thema
Genovate Biotechnology Co., Ltd. Genovate Biotechnology Co., Ltd.

Genovate Biotechnology Co., Ltd.

4130
Rang in Aktien #21465
Genovate Biotechnology Co., Ltd. is a Taiwanese enterprise dedicated to the... Genovate Biotechnology Co., Ltd. is a Taiwanese enterprise dedicated to the research, development, production, and commercialization of various products. These offerings primarily aim to prevent and treat illnesses resulting from viral and bacterial infections. The company's diverse portfolio extends to drugs, active pharmaceutical ingredients (APIs), intermediates, and specialized release agents, which are crucial for addressing a range of health issues including cardiovascular, esophageal, gastrointestinal, cancer, and autoimmune conditions. Complementing its pharmaceutical offerings, Genovate also manufactures controlled-release Western medicine formulations and cosmetic items. Established in 1982, the company's operations are headquartered in Hsinchu City, Taiwan.
Aktienkurs
$0.84903405
Zuletzt synchronisiert: 2026-07-27
Marktkapitalisierung
$106.63M
Veränderung (1 Tag)
0.00%
Veränderung (1 Jahr)
38.69%
Land
TW
Handel Genovate Biotechnology Co., Ltd. (4130)

Kategorie

Healthcare
P/S-Verhältnis für Genovate Biotechnology Co., Ltd. (4130)
P/S-Verhältnis zum 2026 TTM: 0
Laut den neuesten Finanzberichten und dem Aktienkurs von Genovate Biotechnology Co., Ltd. beträgt das aktuelle Kurs-Umsatz-Verhältnis (TTM) 0. Am Ende des Jahres 2026 lag das P/S-Verhältnis bei 0.
P/S-Verlauf für Genovate Biotechnology Co., Ltd. von 2026 bis 2026
P/S-Verhältnis zum Jahresende
Jahr P/S-Verhältnis ändert
Nicht genügend Daten für die angegebenen Daten.
P/S-Verhältnis für ähnliche Unternehmen oder Wettbewerber
Unternehmen P/S-Verhältnis P/S-Verhältnis-Differenz Land
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
10.17 -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
10.13 -
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
11.28 -
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
2.95 -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH